Atlas Trials

SGLT2 Inhibitor in Lupus Nephritis Patients With Chronic Kidney Disease

Clinical trial NCT06155604 · RECRUITING

Trial details

NCT number
NCT06155604
Sponsor
The University of Hong Kong
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Lupus NephritisChronic Kidney Diseases
Start date
2023-01-04
Primary completion
2026-12-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.